Stock Analiz

MindWalk Holdings Corp. HYFT

Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026

$0.99Market cap $47M
Open the interactive analysis →

MindWalk Holdings Corp. (HYFT) is a healthcare company listed in the US with a market value of about $47M. In fiscal year 2025 it had revenue of $18M and net income of -$22M, a net margin of -123.3%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 12% a year, a 5-year average ROIC of -54%.

About MindWalk Holdings

MindWalk Holdings is listed in the US and classified in biotechnology: pharmaceutical preparations. Revenue went from $10M in 2020 to $18M in 2025, growth of about 11.8% a year. It was profitable in 0 of the last 6 years in our data.

Score: 1.2 / 5

Value0/5
Future growth0/5
Track record1/5
Financial health4/5
Shareholder returns1/5

Checks passed

  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2.7
P/B2.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-11.1%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-1.0%
Revenue growth (5 yrs, per year)11.8%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-97.1%
ROIC (5-yr avg.)-54.3%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 6 years

Fiscal year202520242023202220212020
Revenue$18M$18M$15M$15M$15M$10M
Net income-$22M-$19M-$19M-$13M-$6M-$4M
Free cash flow-$5M-$3M-$16M-$9M-$2M-$1M
EPS (diluted)$-0.46$-0.40$-0.41$-0.28$-0.13$-0.07
Net margin-123.3%-106.5%-128.5%-86.3%-41.0%-35.2%
ROIC-128.0%-73.2%-45.4%-16.6%-8.3%-32.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does MindWalk Holdings pay a dividend?

Not currently.

Is MindWalk Holdings a good stock to buy?

We do not give buy or sell advice. MindWalk Holdings scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.